Birdwatch Note
2023-11-05 10:01:48 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ELA no tiene cura. A día de hoy, el riluzol es el único medicamento aprobado en Europa específico para esta enfermedad, siendo capaz de extender la supervivencia del paciente una media de tres meses. https://neurologia.com/articulo/98127
Written by A474DFF06D5CEA6395571512581A56471579016A898CC7C130BC41232F3F3766
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1720796972611785048
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1721105526027677722
- noteId - 1721105526027677722
- participantId -
- noteAuthorParticipantId - A474DFF06D5CEA6395571512581A56471579016A898CC7C130BC41232F3F3766 Participant Details
- createdAtMillis - 1699178508659
- tweetId - 1720796972611785048
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ELA no tiene cura. A día de hoy, el riluzol es el único medicamento aprobado en Europa específico para esta enfermedad, siendo capaz de extender la supervivencia del paciente una media de tres meses. https://neurologia.com/articulo/98127
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-05 10:01:48 UTC (1699178508659) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-06 03:03:27 UTC (1699239807439) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-05 07:06:40 -0600 | Rating Details | |
| 2023-11-06 02:47:36 -0600 | Rating Details |